##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



---

FORM 10-QSB/A

(Amendment No. 1)



---

(Mark One)

|x | QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ---------------------------------------------------------------------------------

FOR THE QUARTERLY PERIOD ENDED APRIL 1, 2006



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------------

FOR THE TRANSITION PERIOD FROM             
TO

COMMISSION FILE NUMBER: 000-13858



---

MEDICAL SOLUTIONS MANAGEMENT
INC.

(F/K/A CHINA MEDIA NETWORKS INTERNATIONAL, INC.)

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)



---



|                                         |  |                                     
|---------------------------------------- |  | ------------------------------------
|Nevada                                   |  | 86-0214815                          
|(State of Incorporation)                 |  | (I.R.S. Employer Identification No.)
|                                         | 
|237 Cedar Hill Street, Marlborough, MA   |  | 01752                               
|(Address of principal executive offices) |  | (Zip Code)                          

(508) 597-6300

(Registrants telephone number, including area code)



(Former name, former address and former fiscal year, if changed since last report)



---

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the
past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ̈No  x

Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date. As of October 29, 2007, there were 58,217,994 shares of the registrants common stock issued and
outstanding.

Transitional Small Business Disclosure Format (Check one):    Yes ̈No  x



---



---

##### Table of Contents

TABLE OF CONTENTS



|                                                                  |  |     
|----------------------------------------------------------------- |  | ----
|                                                                  |  | Page
|PART I FINANCIAL INFORMATION                                      |  | 1   
|                                                                  | 
|ITEM 1: FINANCIAL STATEMENTS                                      |  | 1   
|                                                                  | 
|ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATION |  | 8   
|                                                                  | 
|ITEM 3. CONTROLS AND PROCEDURES                                   |  | 13  



---

##### Table of Contents

Explanatory Notes

Medical Solutions Management Inc. is filing this Amendment No. 1 on Form 10-QSB/A to its Form 10-QSB for the quarter ended April 1, 2006, to reflect certain comments received from Staff of the Securities and
Exchange Commission in connection with its review of our Registration Statement on Form SB-2 (File No. 333-136392) and to correct inadvertent errors in accounting.

The information contained in this Amendment No. 1, including the financial statements and the notes hereto, amends only Items 1, 2 and 3 of Part I of our originally filed Quarterly Report on Form 10-QSB for the
quarter ended April 1, 2006 and no other items in our originally filed Form 10-QSB are amended hereby. In accordance with Rule 12b-15 of the Securities and Exchange Act of 1934, the complete text of those items in which amended language appears
is set forth herein, including those portions of the text that have not been amended from that set forth in the original Form 10-QSB. Except for the aforementioned adjustments, this Form 10-QSB/A does not materially modify or update other
disclosures in the original Form 10-QSB, including the nature and character of such disclosure to reflect events occurring after May 15, 2006, the filing date of the original Form 10-QSB. Accordingly this Form 10-QSB/A should be read in
conjunction with our filings made with the Securities and Exchange Commission. Currently dated certifications from the our principal executive officer and principal accounting and finance officer have been included as exhibits to this Amendment
No. 1.

Unless the context otherwise requires, in this annual report on Form 10-KSB/A the term MSMI refers Medical
Solutions Management Inc. (f/k/a China Media Networks International, Inc.) and the term OrthoSupply refers to MSMIs wholly-owned subsidiary, OrthoSupply Management, Inc. The terms the Company, we,
us or our refer to MSMI and OrthoSupply collectively. The term Securities Act refers to the Securities Act of 1933, as amended, the term Exchange Act refers to the Securities Exchange Act of 1934, as
amended, and the term SEC refers to the Securities and Exchange Commission.

Note on Forward-Looking Information

Except for historical facts, the statements in this quarterly report on Form 10-QSB/A are forward-looking statements. Forward-looking statements are
merely our current predictions of future events. These statements are inherently uncertain, and actual events could differ materially from our predictions. Important factors that could cause actual events to vary from our predictions include those
discussed under the headings Risk Factors, Managements Discussion and Analysis or Plan of Operations and Business in our Annual Report on Form 10-KSB/A for fiscal year ended December 31, 2005. We
assume no obligation to update our forward-looking statements to reflect new information or developments. We urge readers to review carefully the risk factors described in the Annual Report on Form 10-KSB/A for fiscal year ended December 31,
2005 and the other documents that we file with the SEC. You can read these documents at www.sec.gov.



---

##### Table of Contents

PART I FINANCIAL INFORMATION

|Item 1: | Financial Statements
|------- | --------------------

Medical Solutions
Management Inc.

(n/k/a China Medial Networks International, Inc.)

Consolidated Balance Sheet (unaudited)

April 1, 2006



|                                                                                                                           |  |                     |            |  
|-------------------------------------------------------------------------------------------------------------------------- |  | ------------------- | ---------- | -
|                                                                                                                           |  | As of April 1, 2006 |           
|                                                                                                                           |  | (Restated)          |           
|Assets                                                                                                                     |  |                     |            |  
|Current Assets                                                                                                             |  |                     |            |  
|Cash & cash equivalents                                                                                                    |  | $                   | 176,841    |  
|Accounts receivable, net                                                                                                   |  |                     | 151,790    |  
|Inventory                                                                                                                  |  |                     | 140,296    |  
|Prepaid expenses                                                                                                           |  |                     | 34,388     |  
|Total current assets                                                                                                       |  |                     | 503,315    |  
|Property & equipment (net)                                                                                                 |  |                     | 96,177     |  
|Total assets                                                                                                               |  | $                   | 599,492    |  
|Liabilities & Stockholders Deficiency                                                                                     |  |                     |            |  
|Current Liabilities:                                                                                                       |  |                     |            |  
|Accounts payable                                                                                                           |  | $                   | 143,022    |  
|Accrued expenses                                                                                                           |  |                     | 175,647    |  
|Demand notes                                                                                                               |  |                     | 0          |  
|Advances from related parties                                                                                              |  |                     | 0          |  
|Convertible notes payable                                                                                                  |  |                     | 25,000     |  
|Total current liabilities                                                                                                  |  |                     | 343,669    |  
|                                                                                                                           | 
|Preferred stock-10,000,000 authorized $0.001 par value 1,700,000 Series A issued and outstanding, net of issuance
costs  |  |                     | 1,346,555  |  
|Stockholders Deficiency:                                                                                                  |  |                     |            |  
|Common stock-100,000,000 authorized $0.0001 par value 19,801,148 issued & outstanding (19,741,146 as of December 31,
2005) |  |                     | 1,980      |  
|Additional paid in capital                                                                                                 |  |                     | 134,656    |  
|Accumulated Deficit                                                                                                        |  |                     | (1,227,368 | )
|Total Stockholders Deficiency                                                                                             |  |                     | (1,090,731 | )
|Total Liabilities & Stockholders Deficiency                                                                               |  | $                   | 599,492    |  

See Notes to Interim Unaudited Interim Financial Statements.



1



---

##### Table of Contents

Medical Solutions Management Inc.

(n/k/a China Medial Networks International, Inc.)

Consolidated Statement of
Operations from January 1, 2006 to April 1, 2006

and the comparative period for Fiscal Year 2005

(unaudited)



|                                                   |  |                                 |            |   |                                              |   |            |  
|-------------------------------------------------- |  | ------------------------------- | ---------- | - | -------------------------------------------- | - | ---------- | -
|                                                   |  | Three MonthsEnded April 1, 2006 |            |   | February 1, 2005(inception) toMarch 31, 2005 |  
|                                                   |  | (Restated)                      |            |   | (Restated)                                   |  
|Revenue:                                           |  |                                 |            |   |                                              |   |            |  
|Sales of Medical Products                          |  | $                               | 125,793    |   |                                              | $ | 19,635     |  
|Service Revenue                                    |  |                                 | 27,870     |   |                                              | $ | 1,219      |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|Total revenue                                      |  |                                 | 153,663    |   |                                              | $ | 20,854     |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|Cost of Sales:                                     |  |                                 |            |   |                                              |   |            |  
|Cost of Medical Products                           |  |                                 | 92,016     |   |                                              |   | 30,939     |  
|Cost of Services                                   |  |                                 | 17,907     |   |                                              |   | 1,481      |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|Costs Applicable to Sales & Revenue                |  |                                 | 109,923    |   |                                              |   | 32,420     |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|Gross Profit                                       |  |                                 | 43,740     |   |                                              |   | (11,566    | )
|                                                   |  |                                 | 28.5       | % |                                              |   | n/a        |  
|Selling, General & Administrative Expenses         |  |                                 | 493,975    |   |                                              |   | 41,443     |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|Total Operating Expenses                           |  |                                 | 493,975    |   |                                              |   | 41,443     |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|(Loss) Before Other Income                         |  |                                 | (450,235   | ) |                                              |   | (53,009    | )
|Other Income (Expense)                             |  |                                 |            |   |                                              |   |            |  
|Interest Income                                    |  |                                 | 2,009      |   |                                              |   | 12         |  
|Other Income                                       |  |                                 | 0          |   |                                              |   | 0          |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|Interest (expense), net                            |  |                                 | 0          |   |                                              |   | 0          |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|(Loss) Before Income Taxes                         |  |                                 | (448,226   | ) |                                              |   | (52,997    | )
|                                                   |  |                                 |            |   |                                              |   |            |  
|Income Taxes                                       |  |                                 | 669        |   |                                              |   | 0          |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|Net Loss available to common shareholders          |  | $                               | (448,895   | ) |                                              | $ | (52,997    | )
|                                                   |  |                                 |            |   |                                              |   |            |  
|Basic and Diluted Net Loss Per Common Share        |  | $                               | (0.02      | ) |                                              | $ | 0.00       |  
|                                                   |  |                                 |            |   |                                              |   |            |  
|Weighted Average Common Shares Outstanding (Basic) |  |                                 | 19,766,201 |   |                                              |   | 16,414,419 |  

See Notes to Interim Unaudited Interim Financial Statements.



2



---

##### Table of Contents

Medical Solutions Management Inc.

(n/k/a China Medial Networks International, Inc.)

Consolidated Statement of
Cash Flows from January 1, 2006 to April 1, 2006

and the comparative period for Fiscal Year 2005

(unaudited)



|                                            |  |                                |          |   |                                              |   |         |  
|------------------------------------------- |  | ------------------------------ | -------- | - | -------------------------------------------- | - | ------- | -
|                                            |  | Three MonthsEndedApril 1, 2006 |          |   | February 1, 2005(inception) toMarch 31, 2005 |  
|                                            |  | (Restated)                     |          |   | (Restated)                                   |  
|Cash Flows from Operating Activities:       |  |                                |          |   |                                              |   |         |  
|Net Income                                  |  | $                              | (448,895 | ) |                                              | $ | (52,997 | )
|Increase in allowance for doubtful accounts |  |                                | 29,702   |   |                                              |   | 0       |  
|Depreciation, Amortization & Bad Debts      |  |                                | 8,800    |   |                                              |   | 0       |  
|Stock issued for services                   |  |                                | 15,000   |   |                                              |   | 0       |  
|Changes in Operating Assets & Liabilities   |  |                                |          |   |                                              |   |         |  
|Accounts receivable                         |  |                                | (55,136  | ) |                                              |   | (21,630 | )
|Inventory                                   |  |                                | (31,258  | ) |                                              |   | 13,801  |  
|Prepaid expenses                            |  |                                | (6,869   | ) |                                              |   | 0       |  
|Accounts payable                            |  |                                | (174,969 | ) |                                              |   | 532     |  
|Accrued expenses                            |  |                                | 143,047  |   |                                              |   | 0       |  
|Loan payable                                |  |                                |          |   |                                              |   |         |  
|                                            |  |                                |          |   |                                              |   |         |  
|Convertible notes payable                   |  |                                |          |   |                                              |   | 0       |  
|                                            |  |                                |          |   |                                              |   |         |  
|Net cash used by operating activities       |  |                                | (520,578 | ) |                                              |   | 0       |  
|                                            |  |                                |          |   |                                              |   |         |  
|Cash Flows from Investing Activities:       |  |                                |          |   |                                              |   |         |  
|Purchase of Equipment                       |  |                                | (2,321   | ) |                                              |   | 0       |  
|Net cash used by investing activities       |  |                                | (2,321   | ) |                                              |   | 0       |  
|Cash Flows from Financing Activities:       |  |                                |          |   |                                              |   |         |  
|Proceeds from preferred offering            |  |                                | 0        |   |                                              |   | 0       |  
|Proceeds from issuance of common stock      |  |                                | 0        |   |                                              |   | 50,000  |  
|Purchase of treasury stock                  |  |                                | 0        |   |                                              |   | 0       |  
|Payment of offering costs                   |  |                                | 0        |   |                                              |   | 0       |  
|Borrowings from related parties             |  |                                | 0        |   |                                              |   | 10,437  |  
|Payment of related party debt               |  |                                | 0        |   |                                              |   | 0       |  
|                                            |  |                                |          |   |                                              |   |         |  
|Net cash used by financing activities       |  |                                | 0        |   |                                              |   | 0       |  
|                                            |  |                                |          |   |                                              |   |         |  
|Net Change In Cash                          |  |                                | (522,899 | ) |                                              |   | 143     |  
|Cash-Beginning                              |  |                                | 699,740  |   |                                              |   | 0       |  
|                                            |  |                                |          |   |                                              |   |         |  
|Cash-Ending                                 |  | $                              | 176,841  |   |                                              | $ | 143     |  
|                                            |  |                                |          |   |                                              |   |         |  

See Notes to Interim Unaudited Interim Financial Statements.



3



---

##### Table of Contents

MEDICAL SOLUTIONS MANAGEMENT INC.

(f/k/a China Media Network International, Inc.)

NOTES TO INTERIM UNAUDITED
FINANCIALS STATEMENTS

1. Basis of Presentation

The Financial Statements presented herein have been prepared by us in accordance with the accounting policies described in our Annual Report on Form 10-KSB/A for fiscal year ended December 31, 2005 and should be
read in conjunction with the Notes to Consolidated Financial Statements which appear in that report.

The preparation of these financial
statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of
contingent assets and liabilities. On an on going basis, we evaluate our estimates, including those related intangible assets, income taxes, insurance obligations and contingencies and litigation. We base our estimates on historical experience and
on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other resources.
Actual results may differ from these estimates under different assumptions or conditions.

In the opinion of management, the information
furnished in this Form 10-QSB/A reflects all adjustments necessary for a fair statement of the financial position and results of operations and cash flows as of and for the three-month periods ended April 1, 2006 and 2005. All such adjustments
are of a normal recurring nature. The Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-QSB/A and therefore do not include some information and notes necessary to conform with annual reporting
requirements.

2. Earnings/Loss Per Share

Basic earnings per share are computed by dividing income available to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. Diluted earnings per share assume that
any dilutive convertible securities outstanding were converted, with related preferred stock dividend requirements and outstanding common shares adjusted accordingly. It also assumes that outstanding common shares were increased by shares issuable
upon exercise of those stock options for which market price exceeds the exercise price, less shares which could have been purchased by us with the related proceeds. In periods of losses, diluted loss per share is computed on the same basis as basic
loss per share as the inclusion of any other potential shares outstanding would be anti-dilutive.

3. New Accounting Standards

In May 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections, which replaces APB Opinion No. 20 Accounting
Changes, and FASB Statement No. 3 Reporting Accounting Changes in Interim Financial Statements, and changes the requirements for the accounting for and reporting of a change in accounting principle. This Statement requires
retrospective application to prior periods financial statements of changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. This Statement shall be
effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. Early adoption is permitted for accounting changes and corrections of errors made in fiscal years beginning after the date this
Statement is issued. We do not believe that adoption of SFAS 154 will have a material impact on our financial statements.



4



---

##### Table of Contents

4. Stockholders Deficiency

Recent Sales of Unregistered Securities

On February 22, 2006, the Company terminated its
agreement with The Baum Law Firm as special counsel for the company. As part of the termination and release agreement, we agreed to pay The Baum Law Firm an aggregate sum of $30,000 and 60,000 shares of common stock of MSMI valued at $ 15,000.

5. Stock-Based Compensation-Adoption of SFAS 123R

On January 1, 2006, the Company adopted the provisions of Statement of Financial Accounting Standards (SFAS) 123R, Share-Based Payment (SFAS 123(R)), which requires that
companies measure and recognize compensation expense at an amount equal to the fair value of share-based payments granted under compensation arrangements. Prior to January 1, 2006, the Company accounted for its stock-based compensation plans
under the recognition and measurement principles of Accounting Principles Board (APB) Opinion 25, Accounting for Stock Issued to Employees, and related interpretations, and recognized no compensation expense for stock option
grants since all options granted had an exercise price equal to the market value of the underlying common stock on the date of grant.

The
Company adopted SFAS 123(R) using the modified prospective method, which results in no restatement of prior period amounts. Under this method, the provisions of SFAS 123(R) apply to all awards granted or modified after the date of
adoption. In addition, compensation expense must be recognized for any unvested stock option awards outstanding as of the date of adoption on a straight-line basis over the remaining vesting period. The Company calculates the fair value of options
using a Black-Scholes option pricing model. For the three months ended April 1, 2006, the Companys compensation expense related to stock option grants was considered immaterial. The Company did not grant any options during the three
months ended April 1, 2006.

SFAS 123(R) also requires the benefits of tax deductions in excess of recognized compensation expense to
be reported in the Statement of Cash Flows as a financing cash inflow rather than an operating cash inflow. In addition, SFAS 123(R) required a modification to the Companys calculation of the dilutive effect of stock option awards on earnings
per share. For companies that adopt SFAS 123(R) using the modified prospective method, disclosure of pro forma information for periods prior to adoption must continue to be made.

As of April 1, 2006, there was no unrecognized compensation cost related to non-vested options granted under the plan. The total fair value of
shares vested during the three-month period ended April 1, 2006 was $0 (none during the three-month period ended March 31, 2005).

The following table summarizes the status of the Companys aggregate options and warrants as of April 1, 2006:



|                         |  |                                 |   |                                        |                               |                                 |  |        |  |                               |  |   |     
|------------------------ |  | ------------------------------- | - | -------------------------------------- | ----------------------------- | ------------------------------- |  | ------ |  | ----------------------------- |  | - | ----
|                         |  | Options and WarrantsOutstanding |   | Weightedaverageremaining lifein months |                               | Options and WarrantsExercisable
|Range of exercise prices |  | Shares                          |   |                                        | weightedaverageexercise price |                                 |  | Shares |  | weightedaverageexercise price
|$ .01-$ .74              |  | 600,000                         | * |                                        | $                             | 0.01                            |  | 48.6   |  | 600,000                       |  | $ | 0.01
|$ .75-$ 1.75             |  | 5,777,335                       |   |                                        | $                             | 1.45                            |  | 78.4   |  | 5,777,335                     |  | $ | 1.45
|                         |  |                                 |   |                                        |                               |                                 |  |        |  |                               |  |   |     
|Total Shares             |  | 6,377,335                       |   |                                        |                               |                                 |  |        |  | 6,377,335                     |  |   |     
|                         |  |                                 |   |                                        |                               |                                 |  |        |  |                               |  |   |     



5



---

##### Table of Contents

|                                                      |  |           |   |  |                              |      |                                                |       |                          |     
|----------------------------------------------------- |  | --------- | - |  | ---------------------------- | ---- | ---------------------------------------------- | ----- | ------------------------ | ----
|                                                      |  | Shares    |   |  | WeightedAverageExercisePrice |      | WeightedAverageRemainingContractualTerm(Years) |       | AggregateIntrinsic Value
|Options and warrants outstanding at December 31, 2005 |  | 6,377,335 | * |  | $                            | 1.31 |                                                |       |                          |     
|Granted                                               |  |          |   |  |                              |     |                                                |       |                          |     
|Exercised                                             |  |          |   |  |                              |     |                                                |       |                          |     
|Forfeited                                             |  |          |   |  |                              |     |                                                |       |                          |     
|                                                      |  |           |   |  |                              |      |                                                |       |                          |     
|Options and warrants outstanding at April 1, 2006     |  | 6,377,355 |   |  | $                            | 1.31 |                                                | 75.75 |                          | none
|                                                      |  |           |   |  |                              |      |                                                |       |                          |     
|Options and warrants exercisable at April 1, 2006     |  | 6,377,355 |   |  | $                            | 1.31 |                                                | 75.75 |                          | none
|                                                      |  |           |   |  |                              |      |                                                |       |                          |     

---

|* | Includes options to purchase an aggregate 600,000 shares of common stock of OrthoSupply to be converted to substantially equivalent options in MSMI upon approval of an equity
compensation plan by the Board of Directors and shareholders of MSMI.
|- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

6. Managements Plan

There is substantial doubt about the companys ability to continue as a going concern. Our main objectives for the next 12 months are continuing our
ability to finance the Company and focusing on expanding revenue in key locations across the country. Our current cash availability will support current operations through the first three months of 2006. Our current monthly burn rate is about
$250,000. In addition we invested approximately $40,000 to upgrade our information technology and accounting systems. We anticipate that we need to complete additional follow-on financing to support current working capital needs and potential
acquisitions. Through these financings, we hope to expand the business organically and acquisitively.

Our plan for organic growth includes
increasing our sales force in key locations across the country. In fiscal year 2006, we plan to hire a Vice President of Sales and Marketing and build our sales force from our current level, 2 sales people, to 10 sales people. The plan includes
support programs for the sales efforts including marketing, communications and program literature.

We also plan to increase our resources
in accounting and administration, and to hire additional employees to assist with our back-office administration. We expect to hire additional field support resources to support the growth in new clinics during 2006.

We do not anticipate devoting our resources to research and development in fiscal year 2006.

We continue to pursue opportunities that will add to our current product and service offerings in an effort to fulfill the current demands in place, as
well as, drive the continuous improvement of the billing and inventory processes that support the clinics.

7. Subsequent Events

On April 13, 2006, the Company entered into an Exchange Agreement with certain of the Companys existing shareholders, whereby such shareholders
assigned, exchanged and converted their right, title and interest, if any, to shares of the Companys Series A Preferred Stock and, in exchange therefor and upon such conversion, the Company issued such shareholders shares of the Companys
common stock. As a result, there are no shares of the Companys Series A Preferred Stock presently outstanding.

On May 3, 2006,
the Company entered into a Securities Purchase Agreement with Vicis Capital Master Fund, one of its existing shareholders. Pursuant to the Securities Purchase Agreement, the Company sold to Vicis Capital Master Fund a convertible note in the
original principal amount of $300,000 and 300,000 shares of the Companys common stock, in exchange for $300,000. The terms of these agreements have been superseded and replaced by a June 28, 2006, agreement whereby we issued a
$2.0 million convertible promissory note. The note



6



---

##### Table of Contents

bears interest at 6% per annum until paid or converted. Interest is payable quarterly commencing September 30, 2006. The convertible note matures
on June 27, 2008. The conversion rate is approximately $0.21 per share (subject to certain anti-dilution provisions).

8. Restatement of
Financial Statements

In connection with the filing of a registration statement on Form SB-2 with the SEC, we received a comment letter
from the staff of the Securities and Exchange Commission asking for additional information regarding our Preferred Stock. Upon review, we have determined that we have accounted for our Preferred Stock in error. Previously, we classified the
Preferred Stock as a component of stockholders equity, however, we have subsequently determined the provision in the certificate of designation allowing the holders of a majority of the issued and outstanding shares of Series A Preferred Stock
to elect, upon a change in control of the Company, to cause the Company to redeem all or a portion of the issued and outstanding shares of Series A Preferred Stock, at a per share price equal to $1.00 plus accrued dividends to be not solely within
our control. United States S.E.C. Reg. S-X Rule 5-02(28) requires public companies to report such redeemable preferred stock outside stockholders equity. We also changed the carrying value from stated redemption value to fair value measured
initially at the gross proceed less direct offering costs incurred. Such costs totaled $353,445. These costs were previously reported as a reduction of additional paid-in capital. Accordingly we have reduced previously stated total
stockholders equity by the carrying value of the preferred stock of $1,346,555. These changes also increased additional paid-in capital by the amount of the preferred offering costs of $353,445.

We have also determined our previous accounting for the reverse merger was in error. For financial reporting purposes, OrthoSupply Management, Inc. was
treated as the acquiring company and the transaction should have been accounted for as a recapitalization. At the date of recapitalization, December 30, 2005, China Media Networks International, Inc. was a public shell company, defined as an
inactive, publicly-quoted company with nominal assets and liabilities. The restated Statement of Stockholders Equity in compliance with U.S. GAAP eliminates all references to China Media Networks International, Inc. prior to the
recapitalization and replaces it with a reporting of the chronological transactions of the deemed accounting acquiror, OrthoSupply Management, Inc. Because OrthoSupply Management, Inc. began business in 2005, there are no transactions for all
periods preceding 2005. The restated treatment of the acquisition as a recapitalization had no impact on previously stated stockholders equity accounts but the chronological issuance of shares of OrthoSupply Management, Inc. differed from the
chronological issuance of shares of China Media Networks International, Inc. The change in reporting resulted in the weighted average shares outstanding during 2005 to increase from 503,142 to 16,414,419. We have restated our Balance Sheet as of
April 1, 2006 and March 31, 2005 and the Statements of Operations and Shareholders Deficit for the period then ended to correctly reflect these items.

Schedule of Journal entries:



|                                                                                                                                                                                                                                                                                                                                         |  |         |  |        
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | ------- |  | -------
|Adjustment 1                                                                                                                                                                                                                                                                                                                             |  |         |  |        
|Preferred stock                                                                                                                                                                                                                                                                                                                          |  | 353,445 |  |        
|Additional paid-in capital to reclassify Preferred stock offering expenses as a reduction in the carrying value of the Preferred instead of a
reduction of common stock additional paid-in capital and adjust the carrying value of the preferred from redemption value to fair value estimated as proceeds net of direct offering costs |  |         |  | 353,445

Schedule of adjustments and impact on amounts previously reported and the revised balances:



|                             |  |             |   |  |              |   |  |            |  
|---------------------------- |  | ----------- | - |  | ------------ | - |  | ---------- | -
|                             |  | As reported |   |  | Adjustment 1 |   |  | Restated   |  
|Balance Sheet:               |  |             |   |  |              |   |  |            |  
|Redeemable preferred stock   |  | 1,700,000   |   |  | (353,445     | ) |  | 1,346,555  |  
|Common stock                 |  | 1,980       |   |  |              |   |  | 1,980      |  
|Additional paid-in capital   |  | (218789     | ) |  | 353,445      |   |  | 134,656    |  
|Accumulated deficit          |  | (1,227,367  | ) |  |              |   |  | (1,227,367 | )
|Total Shareholder Deficiency |  | 255,823     |   |  | (1,346,555   | ) |  | (1,090,731 | )



7



---

##### Table of Contents

|ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.
|------- | ----------------------------------------------------------

The following discussion and analysis of our financial condition and plan of operations should be read in conjunction with the financial statements and the related notes. This discussion contains forward-looking
statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Our actual results and the timing of certain events could differ materially from those anticipated in these
forward-looking statements as a result of certain factors, including those set forth in Annual Report on Form 10-KSB/A for the fiscal year ended December 31, 2005 under Risk Factors, Managements Discussion and Analysis
or Plan of Operations and Business.

Background

On December 30, 2005, China Media Networks International, Inc. (n/k/a Medical Solutions Management Inc.) consummated a merger transaction with its
then wholly-owned subsidiary, CMNW Acquisition Corporation, OrthoSupply Management, Inc., Thunderbird Global Corporation and Mark L. Baum. Pursuant to the merger, CMNW Acquisition Corporation merged with and into OrthoSupply Management, Inc., CMNW
Acquisition Corporation ceased to exist, and OrthoSupply Management, Inc. continued as the surviving corporation and wholly-owned subsidiary of China Media Networks International, Inc. OrthoSupply Management, Inc. acts as our operating company and
MSMI is the parent holding company, and sole stockholder, of OrthoSupply Management, Inc.

OrthoSupply Management, Inc. has generated
revenue from its operation since February 2005. The discussion below focuses upon OrthoSupply Management, Inc.s financial condition, results of operations and liquidity and capital resources.

Our Business

We are a provider of orthopedic
and podiatric durable medical equipment, specializing in the provision of products and services using our turnkey program. Through our turnkey program, we enable orthopedic and podiatric practices to dispense an array of durable medical equipment
directly to their patients during office visits. The system, which is transportable to other types of medical practices, also provides billing services, inventory management and insurance verifications.

Results of Operations

We operate our business
on a calendar year basis, with our fiscal year ending on December 31.

Net Revenue. For the first three months ended
April 1, 2006, we had revenues of $153,663, including $125,793 from the sale of products and $27,870 from services. Due to the designed billing contracts an additional $12,000 in revenue was recorded in the first quarter. In accordance with the
contracts in place with the initial group of clinics, after 90 days the clinic is responsible to purchase the inventory on-hand as well as any goods delivered going forward on a monthly basis. This inventory ownership billing resulted in the
additional $12,000 in revenue for the first quarter. As a result of amendments to our existing contracts, $29,000 of revenue was not recorded in the first quarter. OrthoSupply, MSMIs wholly owned subsidiary, had revenues of $20,854, including
$19,635 from product sales and 1,219 from services for the comparable quarter in 2005.

Cost of Sales. Cost of sales as a
percentage of net sales for the first three months ended April 1, 2006 were $109,903 or 72% of revenue including $92,016 for product cost (73% of product sales) and $17,907 of service cost (64% of service revenue). These amounts represent the
costs associated with the medical products and services we supply to our clients. OrthoSupply, MSMIs wholly owned subsidiary, had costs of sales equal to $32,420 or 155% of revenue including $30,939 of product cost (156% of product sales) and
$1,481 for cost of services (121% of service revenue) for the comparable quarter in 2005.



8



---

##### Table of Contents

Operating Expenses. Total operating expenses were $493,975 for the first three months ended
April 1, 2006. Salaries and benefits to our employees accounted for 44%, or $218,633, of our operating expenses. Legal, consulting, and insurance expenses accounted for 38%, or $188,141, of our operating expenses. OrthoSupply, MSMIs
wholly owned subsidiary, had total operating expenses for the comparable quarter in 2005 of $41,443. Salaries and benefits accounted for 62%, or $25,522, of the total operating expenses.

Net Loss. Net loss for the first three months ended April 1, 2006 was $448,895. This loss was attributable to selling and
administrative costs as OrthoSupply continues to ramp up its operations, introducing new clinics and organized support for future clinics. OrthoSupply, MSMIs wholly owned subsidiary, had a Net loss for the comparable quarter in 2005 of
$52,997, resulting from start-up costs for the first three months of operation.

Liquidity and Capital Resources

Cash used in operations during the first three months ended April 1, 2006 was $520,578. As of April 1, 2006 we had $599,492 in total assets, of
which $176,841 was in cash and cash equivalents, and our total liabilities were $343,669. We are currently in the process of raising capital through an equity and debt financing to sustain operations for 2006 and beyond. Our current monthly burn
rate is about $250,000.

Our reserve for doubtful accounts. Our reserve amount is based upon estimated losses for
customers who were billed directly for products and services. For the first three months ended April 1, 2006, we reserved 27% of revenues, or $41,730. The reserve amount is based on the sum of accounts receivable greater than 120 days. However,
an additional reserve of $29,000 was posted due to amendments to our existing contracts, with regard to inventory ownership as stated within the original contract. We have not written off any accounts receivable to date.

Our reserve for excess or obsolete inventories. We provide reserves for estimated excess, obsolete and shrink during the start-up phase of
a clinic. For the first three months ended April 1, 2006, we have provided $948 for a reserve, as a result of the following method. Our reserve formula is based on 5% of the inventory value for clinics launched within 90 days of the period
ended April 1, 2006.

Plan of Operations

There is substantial doubt about the companys ability to continue as a going concern. Our main objectives for the next 12 months are to continue our ability to finance the Company and to focus on expanding
revenue in key locations across the country. We are currently pursuing additional follow-on financings to support current working capital needs and potential acquisitions. Our current monthly burn rate is about $250,000. On May 3, 2006, the
Company entered into a Securities Purchase Agreement with one of its existing shareholders. Pursuant to the Securities Purchase Agreement, the Company sold a convertible note in the original principal amount of $300,000 and 300,000 shares of the
Companys common stock, in exchange for $300,000. The terms of these agreements have been superseded and replaced by a June 28, 2006, agreement whereby we issued a $2.0 million convertible promissory note. The note bears interest at
6% per annum until paid or converted. Interest is payable quarterly commencing September 30, 2006. The convertible note matures on June 27, 2008. The conversion rate is approximately $0.21 per share (subject to certain
anti-dilution provisions).

Our plan for organic growth includes increasing our sales force in key locations across the country. In fiscal
year 2006, we plan to build our sales force from our current level of 3 sales people to 7 regional sales people. The plan includes support programs for the sales efforts including marketing, communications and program literature.

We have invested approximately $40,000 to upgrade our information technology and accounting systems. We also plan to increase our resources in
administration, and to hire one to three additional employees to assist with our back-office administration. During the first quarter we hired one additional back-office customer support representative and two field representatives in order to carry
out our current customer service model.

We do not anticipate devoting our resources to research and development in fiscal year 2006.



9



---

##### Table of Contents

We continue to pursue opportunities that will add to our current product and service offerings in an
effort to fulfill the current demands in place, as well as, drive the continuous improvement of the billing and inventory processes that support the clinics.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of
operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make
estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to
contractual allowances, doubtful accounts, inventories, rebates, product returns, warranty obligations, income taxes, intangibles and investments. We base our estimates on historical experience and on various other assumptions that we believe
to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions.

We believe the following critical accounting policies affect our more significant
judgments and estimates used in the preparation of our consolidated financial statements, and this discussion and analysis of our financial condition and results of operations.

Revenue Recognition:Our principal sources of revenues are from the sale of medical products and from providing related management
services. Our revenue recognition policies are in compliance with Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition, SAB No. 101, Revenue Recognition in Financial Statements, EITF Issue No. 00-21,
Revenue Arrangements with Multiple Deliverables, and EITF Issue No. 99-19, Reporting Revenue Gross as a Principal versus Net as an Agent. Revenue is recognized when persuasive evidence of an agreement with the customer
exists, products are shipped or title passes pursuant to the terms of the agreement with the customer, the amount due from the customer is fixed or determinable, collectibility is reasonably assured, and there are no significant future performance
obligations. Service revenues are recognized at the time of performance and usually billed monthly. Revenues from separate service maintenance agreements are recognized ratably over the term of the agreements.

These policies require management, at the time of the transaction, to assess whether the amounts due are fixed or determinable, collection is reasonably
assured, and no future performance obligations exist. These assessments are based on the terms of the agreement with the customer, past history and creditworthiness of the customer. If management determines that collection is not reasonably assured
or future performance obligations exist, revenue recognition is deferred until these conditions are satisfied.

Our sources of revenue are
generated from the sale of products and services.

Sales of products-sales of durable medical equipment, or DME, primarily to
orthopedic and podiatry clinical practices:



| |  |  | Direct Purchase Model-Under this arrangement the clinic places an order with the Company, which then places the actual DME product order to one of its suppliers.
Title to the product is transferred to the Company upon shipment from the supplier. The Company bills the clinic upon confirmation of receipt and acceptance of the delivered products. Upon billing, the Companys performance obligation is
considered fulfilled and, accordingly, revenue is recognized at that time. .
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Purchase as Dispensed Model- Under the purchase as dispensed model, the order and shipping process, payment terms, and pricing is the same as described
above. However, in this model, the product remains the property of the Company upon delivery to the clinic. The product is considered as the Companys inventory held at the clinic site until it is dispensed to a patient. Once dispensed, it
becomes billable to the clinic. Upon billing, the Companys performance obligation is considered fulfilled and, accordingly, revenue is recognized at that time.
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



10



---

##### Table of Contents

We have evaluated the gross sales reporting criteria set forth in paragraphs 7-14 of EITF 99-19 and
determined all our sales of goods and products are required to be reported on a gross basis.

Sales of services-sales of third party
billing and collection services and Physician Extenders services:



| |  |  | Billing and Collection services model-The Company also provides certain clinics with third party billing and collection services. Under this program, the Company
provides clinics with patient agreements which are filled in with DME product information dispensed to a patient along with proper coding. The Company periodically receives this information from the clinic and inputs it into an electronic billing
system for transmittal, on behalf of the clinic, to the appropriate third party payers. The Company charges a fee for this service equal to a fixed percentage of the amounts actually collected by the clinic. The service fee revenue is recognized, on
a net basis, upon collection of the third party billings and is invoiced to clinics on a monthly basis. We have evaluated the net sales reporting criteria set forth in paragraph 16 of EITF 99-19 and determined all our billing and collection services
are required to be reported on a net basis. Billing and collection contract terms are for one to two years with termination subject to thirty days notice for cause, and 90 to 120 day notice without cause.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Physician Extenders (PE) services model- PEs are generally Certified Athletic Trainers. These health care professionals are employed by the Company but work
on site at one or more clinics. They assist the clinic in DME dispensing, inventory management, injury evaluation, prevention and rehabilitation. The Company charges a contractually agreed upon flat fee to the clinic for this service. The fee is
invoiced monthly. Related fee revenue is recognized at the end of each month that the service has been provided and costs are included in cost of sales. Contract terms are generally the same as those of Billing and Collecting services.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In accordance with EITF Issue 00-10, Accounting for Shipping and Handling Fees and Costs, we included all
shipping and handling billings to customers in revenues, and freight costs incurred for product shipments have been included in cost of products sold.

Fair Value of Financial Instruments:Our financial instruments consist of cash and cash equivalents, trade accounts receivable, accounts payable, accrued expenses, and long and short-term borrowings. The
fair value of these instruments approximates their recorded value. We do not have financial instruments with off-balance sheet risk. The fair value estimates were based on market information available to management as of July 1, 2006.

A concentration of credit risk may exist with respect to trade receivables. We perform ongoing credit evaluations of customers and
generally do not require collateral from our customers. We review accounts receivable on a regular basis to determine if any such amounts may be potentially uncollectible. We establish a general reserve based on a range of percentages applied to
accounts receivable aging categories. These percentages are based on historical collection and write-off experience. We include any balances that are determined to be uncollectible, along with the general reserve, in the overall allowance for
doubtful accounts.

Valuation of Long-Lived Assets:We review the recoverability of our long-lived assets, including
buildings, equipment and intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the
carrying value of the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these cash flows are less than the carrying value of such asset, an impairment loss is recognized for
the difference between estimated fair value and carrying value. Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires management to make estimates of these cash flows related to long-lived
assets, as well as other fair value determinations.

Accounting for Obligations and Instruments Potentially to be Settled in the
Companys own Stock: We account for obligations and instruments potentially to be settled in the Companys stock in accordance with EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed To, and
Potentially Settled In a Companys Own Stock. This issue addresses the initial balance sheet classification and measurement of



11



---

##### Table of Contents

contracts that are indexed to, and potentially settled in, the Companys own stock. We account for warrants issued in connection with financing
arrangements in accordance with EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Companys Own Stock. Pursuant to EITF Issue No. 00-19, an evaluation of
specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as a derivative liability. The fair value of warrants classified as derivative liabilities is adjusted for changes in fair
value at each reporting period, and the corresponding noncash gain or loss is recorded in current period earnings

Income Taxes:We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in
the timing of recognition of revenue and expense for tax and financial statement purposes.

Recent Accounting Pronouncements

On December 16, 2004, the Financial Accounting Standards Board (FASB) issued FASB Statement No. 123 (revised 2004), Share-Based Payment, which
is a revision of FASB Statement No. 123, Accounting for Stock-Based Compensation. Statement 123(R) supersedes APB Opinion No. 25, Accounting for Stock Issued to employees, and amends FASB Statement No. 95, Statement of Cash Flows. The
approach to accounting for share-based payments in Statement 123(R) is similar to the approach described in Statement 123. However, Statement 123(R) requires all share-based payments to employees, including grants of employee stock options, to be
recognized in the financial statements based on their fair values and no longer allows pro forma disclosure as an alternative to financial statement recognition. We were required to adopt Statement 123(R) at the beginning of our quarter
January 1, 2006.

Off Balance Sheet Arrangements

We do not have any off balance sheet arrangements.



12



---

##### Table of Contents

|ITEM 3. | CONTROLS AND PROCEDURES
|------- | -----------------------

Evaluation of
disclosure controls and procedures.

As required by Rule 13a-15 under the Exchange Act, as of the end of the period covered by this
report, we carried out an evaluation under the supervision and with the participation of our management, including our President and Treasurer (our acting principal executive officer and principal accounting and finance officer), of the
effectiveness of the design and operation of our disclosure controls and procedures. In designing and evaluating our disclosure controls and procedures, we and our management recognize that any controls and procedures, no matter how well designed
and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily was required to apply its judgment in evaluating and implementing possible controls and procedures. The effectiveness of
our disclosure controls and procedures and our internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events,
the soundness of our systems, the possibility of human error, and the risk of fraud. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in
conditions and the risk that the degree of compliance with policies or procedures may deteriorate over time. Because of these limitations, there can be no assurance that any system of disclosure controls and procedures or internal control over
financial reporting will be successful in preventing all errors or fraud or in making all material information known in a timely manner to the appropriate levels of management.

The Company became aware of the material weakness in connection with the receipt of comments from the Staff on the Securities and Exchange received by
the Company on August 31, 2006 and November 3, 2006 with respect to the Companys Registration Statement on Form SB-2, filed by the Company on August 8, 2006 (File No. File No. 333-136392). A control deficiency exists when
the design or operation of a control does not allow management or employees, in the ordinary course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a control deficiency, or
combination of control deficiencies, that adversely affects the Companys ability to initiate, authorize, record, process, or report external financial data reliably in accordance with GAAP, such that there is a more than remote likelihood that
a misstatement of the Companys annual or interim financial statements that is more than inconsequential will not be prevented or detected. A material weakness is a control deficiency, or combination of control deficiencies, that results in
more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected.

Based upon an evaluation conducted for the period ended April 1, 2006, our President and Treasurer (our acting principal executive officer and principal accounting and finance officer) has concluded that as of the end of the period
covered by this report, we have identified the following material weaknesses:



| |  |  | Reliance upon independent financial reporting consultants for review of critical accounting areas and disclosures and material non-standard transactions.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | A limited number of on-site accounting personnel which results in a lack of segregation of duties necessary for a good system of internal control.
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------

Based on the evaluation of our disclosure controls and procedures as set forth above as of the end of the period covered
by this report, our President (our principal executive officer) and Chief Financial Officer (our principal accounting and finance officer) concluded that, as of such date, our disclosure controls and procedures were not effective at the reasonable
assurance level.

Since the end of period covered by this report, we have undertaken the following steps to remediate the material
weaknesses identifying above:



| |  |  | During the second quarter of 2006, we hired an employee to focus on our purchasing activity to support its growth, and provide segregation of duties from the
controller.
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------



13



---

##### Table of Contents

| |  |  | During the third quarter of 2006, we hired a staff accountant in order to provide greater account processing, and reconciliation capability to further support our
growth, segregation of duties, and controls.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | In the fourth quarter of 2006, we hired a new Chief Financial Officer, who is also qualified as a CPA. As we continue to grow and add clinics and other related
services, additional personnel are planned in both the accounting and operational control areas in subsequent periods.
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Throughout the course of 2006, we hired physician extenders, as more fully described in our revenue recognition policy in the section entitled
Managements Discussion and Analysis or Plan of Operations section of this report and the footnotes to the consolidated financial statements. Physician extenders are Company employees located in the field and who service
one or more clinics for which the Company charges a flat monthly fee. Among other duties, including assisting with Durable Medical Equipment fittings, the physician extenders also monitor clinic inventory and assist the clinic in
determining what and when to order. The physician extenders know what inventory is being dispensed by the clinic and what items are required, so the clinic and the Company can be more proactive in managing and controlling purchases. As an employee
of the Company, the physician extenders are also available to take physical inventory at periodic intervals for purchase as dispensed clinics.
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | We have utilized consultants and other outside professionals throughout fiscal 2006, and will continue in 2007, to assist in reducing its material weakness. We
expect to continue to hire permanent employees and utilize outside experts to support its growth, and enhance its internal controls, including the documentation and testing of its system of internal controls in compliance with Section 404 of
the Sarbanes-Oxley Act of 2002 as amended.
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Managements review of our internal controls is on-going and will take
whatever measures necessary to reduce the material deficiencies noted. Implementation of our remediation plan has included an investment of approximately $40,000 to upgrade our information technology and accounting systems, and is anticipated to
include hiring additional permanent employees, establishing additional training programs and/or engaging outside expert consultants. The effectiveness of the steps we have taken to date and the steps we are still in the process of completing is
subject to continued management review, and we may make additional changes to our internal controls and procedures. Although we have undertaken the foregoing initiatives, we cannot assure you that we will not in the future identify further material
weaknesses in our internal control over financial reporting that we have not discovered to date. We will continue to review and document our disclosure controls and procedures, including our internal controls and procedures for financial reporting,
on an ongoing basis, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that our systems evolve with our business.

Changes in internal control over financial reporting.

There was no change in our internal
control over financial reporting that occurred during the period covered by this report on Form 10-QSB/A that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.



14



---

##### Table of Contents

CHINA MEDIA NETWORKS INTERNATIONAL, INC.

(n/k/a Medical Solutions Management Inc.)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



|                        |  |                                   |  |                              
|----------------------- |  | --------------------------------- |  | -----------------------------
|                        |  | MEDICAL SOLUTIONS MANAGEMENT INC.
|                        |  |                                  
|Date: November 2 , 2007 |  | By:                               |  | /s/    BRIAN
LESPERANCE      
|                        |  |                                   |  | Brian Lesperance             
|                        |  |                                   |  | President and Treasurer      
|                        |  |                                   |  | (principal executive officer)



15



---

##### Table of Contents

EXHIBIT LIST



|            |  |                                                                                                                                                                                                                                               
|----------- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Exhibit No. |  | Description                                                                                                                                                                                                                                   
|            | 
|3.1         |  | Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Registrants Registration Statement on Form SB-2 filed on February 28, 2006)                                                                                       
|            | 
|3.2         |  | Certificate of Amendment (incorporated by reference to Exhibit 3.2 to the Registrants Registration Statement on Form SB-2 filed on February 28, 2006)                                                                                        
|            | 
|3.3         |  | Articles of Merger (incorporated by reference to Exhibit 3.3 to the Registrants Registration Statement on Form SB-2 filed on February 28, 2006)                                                                                              
|            | 
|3.4         |  | Certificate of Amendment (incorporated by reference to Exhibit 3.4 to the Registrants Registration Statement on Form SB-2 filed on February 28, 2006)                                                                                        
|            | 
|3.5         |  | Certificate of Amendment (incorporated by reference to Exhibit 3.5 to the Registrants Registration Statement on Form SB-2 filed on February 28, 2006)                                                                                        
|            | 
|3.6         |  | Certificate of Designations (incorporated by reference to Exhibit 3.6 to the Registrants Registration Statement on Form SB-2 filed on February 28, 2006)                                                                                     
|            | 
|3.7         |  | By-Laws (incorporated by reference to Exhibit 3.7 to the Registrants Registration Statement on Form SB-2 filed on February 28, 2006)                                                                                                         
|            | 
|10.1        |  | DME Supply and Related Services Agreement dated February 1, 2005 by and between the Registrant and Steadman Hawkins Clinic-Denver (incorporated by reference to the Form 10-KSB for the year ended
December 31, 2006 filed on April 16, 2007) 
|            | 
|10.2        |  | DME Supply and Related Services Agreement dated May, 2005 by and between the Registrant and Berkshire Orthopaedic Associates, Inc. (incorporated by reference to the Form 10-KSB for the year
ended December 31, 2006 filed on April 16, 2007)
|            | 
|31.1        |  | Certification of principal executive officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002 (filed herewith)                                                                                                                       
|            | 
|31.2        |  | Certification of principal accounting and finance officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002 (filed herewith)                                                                                                          
|            | 
|32.1        |  | Certification of principal executive officer and principal accounting and finance officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002 (filed herewith)